Target intelligence / Profile preview

Plasmodium protein and nucleic acid synthesis machinery

Molecular classification
Enzyme, Ribosome, Aminoacyl-tRNA synthetase, Other subunit proteins involved in protein and nucleic acid synthesis
01

Overview

The Plasmodium protein and nucleic acid synthesis machinery encompasses all key protein and RNA complexes responsible for transcription and translation within Plasmodium parasites, including RNA polymerases, ribosomes (40S and 60S subunits), and various translation factors and enzymes such as aminoacyl-tRNA synthetases. These molecular systems enable the parasite to read genetic information, generate messenger RNA, and assemble proteins essential for parasite growth, reproduction, and pathogenicity. They differ structurally and functionally from human homologs, offering opportunities for targeted drug development. Investigational and clinically used antimalarial compounds aim to disrupt these molecular machineries, but selectivity and resistance remain significant therapeutic challenges. This entry is too broad for a canonical molecular target form, as it refers to an entire functional class rather than a specific molecule or defined protein complex. For drug-target annotation, it is preferable to specify individual molecular targets (e.g., "Plasmodium ribosomal protein S9" or "Plasmodium RNA polymerase I") rather than the overarching term.

Other names
Plasmodium translation machineryPlasmodium transcription machineryPlasmodium ribosomePlasmodium RNA polymerasePlasmodium protein synthesis machineryPlasmodium nucleic acid synthesis machinery
02

Mechanism of action

Inhibition of protein synthesis (ribosome-binding or translation-blocking drugs); Inhibition of nucleic acid synthesis (blocking RNA polymerase or transcription machinery); Direct interaction/blockade of essential proteins in glideosome and translation complexes

03

Biological functions

Protein synthesis (translation)Nucleic acid synthesis (transcription)Cell proliferationParasite developmentDrug resistance mechanisms (modifications/adaptations can affect drug efficacy)
04

Disease associations

Infection (malaria)
05

Safety considerations

Host toxicity due to off-target effects (similarity in eukaryotic ribosome/RNA polymerase structure between parasite and host)Emergence of drug resistanceSpecific cytotoxicity to human cells with some compounds
06

Interacting drugs

Bedaquiline

9 more in the full profile.

Beyond the preview

Go deeper on Plasmodium protein and nucleic acid synthesis machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium protein and nucleic acid synthesis machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call